Velo3D Faces Delisting Concerns

TL;DR

Velo3D might get kicked off the exchange, big trouble brewing.

AI Summary

Velo3D, Inc. filed an 8-K on July 12, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule. The company, previously known as JAWS Spitfire Acquisition Corp and Spitfire Acquisition Corp, is incorporated in Delaware and headquartered in Fremont, California.

Why It Matters

This filing indicates potential issues with Velo3D's continued listing on an exchange, which could impact its stock price and investor confidence.

Risk Assessment

Risk Level: high — A notice of delisting or failure to meet listing standards is a significant negative event for a publicly traded company.

Key Players & Entities

• Velo3D, Inc. (company) — Registrant
• JAWS Spitfire Acquisition Corp (company) — Former Company Name
• Spitfire Acquisition Corp (company) — Former Company Name
• Delaware (jurisdiction) — State of Incorporation
• Fremont, California (location) — Business Address

FAQ

Key Financial Figures

• $0.00001 — ch registered Common stock, par value $0.00001 per share VLD New York Stock Exchan
• $11.50 — mon stock, each at an exercise price of $11.50 per share VLD WS New York Stock Exc
• $50 million — ive 30 trading-day period was less than $50 million and, at the same time, its stockholders
• $36.6 million — market capitalization was approximately $36.6 million and its last reported stockholders' def
• $45.5 — s of March 31, 2024, was approximately ($45.5) million. In accordance with applicab

Filing Documents

• vld-20240708.htm (8-K) — 56KB
• vld-ex99_1.htm (EX-99.1) — 19KB
• 0000950170-24-083199.txt ( ) — 230KB
• vld-20240708.xsd (EX-101.SCH) — 51KB
• vld-20240708_htm.xml (XML) — 6KB

01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On July 8, 2024, Velo3D, Inc. (the "Company") received written notice (the "Notice") from the New York Stock Exchange (the "NYSE") that the Company is no longer in compliance with NYSE continued listing standards set forth in Section 802.01B of the NYSE's Listed Company Manual due to the fact that the Company's average total market capitalization over a consecutive 30 trading-day period was less than $50 million and, at the same time, its stockholders' equity was less than $50 million. As set forth in the Notice, as of July 5, 2024, the Company's 30 trading-day average market capitalization was approximately $36.6 million and its last reported stockholders' deficit, as of March 31, 2024, was approximately ($45.5) million. In accordance with applicable NYSE procedures, within 45 days from receipt of the Notice, the Company intends to submit a plan to the NYSE advising it of the definitive action(s) the Company has taken, is taking, or plans to take that would bring it into compliance with the continued listing standards within 18 months of receipt of the Notice (the "Cure Period"). The NYSE will review the Company's plan and, within 45 days, make a determination as to whether the Company has made a reasonable demonstration of its ability to come into conformity with the listing standards within the Cure Period. If the NYSE accepts the Company's plan, the Company's common stock will continue to be listed and traded on the NYSE during the Cure Period, subject to the Company's compliance with the other continued listing standards and continued periodic review by the NYSE of the Company's progress with respect to its plan. The Notice has no immediate impact on the listing of the Company's common stock, which will continue to be listed and traded on the NYSE during the Cure Period under the common stock trading symbol "VLD", subject to the Company's contin

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. On July 12, 2024, the Company issued a press release announcing the receipt of the Notice. A copy of the press release is furnished herewith as Exhibit 99.1. The information set forth under this Item 7.01, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release, dated July 12, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Velo3D, Inc. Date: July 12, 2024 By: /s/ Bradley Kreger Name: Bradley Kreger Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR